https://www.sciencedaily.com/news/health_medicine/viruses/ Virology News. Read current research on the virus structure, specific viruses (H5N1 flu, West Nile virus, HIV and more) and responses. en-us Mon, 20 Apr 2026 02:48:15 EDT Mon, 20 Apr 2026 02:48:15 EDT 60 https://www.sciencedaily.com/images/scidaily-logo-rss.png https://www.sciencedaily.com/news/health_medicine/viruses/ For more science news, visit ScienceDaily. https://www.sciencedaily.com/releases/2026/04/260416071953.htm Scientists have uncovered a surprising twist in how bacteria share genes—including those that spread antibiotic resistance. Tiny virus-like particles called gene transfer agents (GTAs), once ancient viral invaders, have been repurposed by bacteria into delivery systems that shuttle DNA between neighboring cells. The study reveals a key control hub of three genes, dubbed LypABC, that triggers bacterial cells to burst open and release these DNA-packed couriers. Fri, 17 Apr 2026 07:44:05 EDT https://www.sciencedaily.com/releases/2026/04/260416071953.htm https://www.sciencedaily.com/releases/2026/04/260414075650.htm Scientists have taken a major step toward stopping Epstein-Barr virus (EBV), an extremely common infection linked to cancer and chronic disease. By using mice engineered with human antibody genes, researchers created powerful human-like antibodies that block the virus from attaching to and entering immune cells. One of these antibodies completely prevented infection in lab models with human immune systems, marking a breakthrough after years of difficulty tackling EBV’s ability to invade nearly all B cells. Wed, 15 Apr 2026 03:26:50 EDT https://www.sciencedaily.com/releases/2026/04/260414075650.htm https://www.sciencedaily.com/releases/2026/04/260411022027.htm A new nanodisc-based platform lets scientists study viral proteins in a form that closely mimics real viruses, revealing how antibodies truly recognize them. This approach uncovered hidden interactions in viruses like HIV and Ebola that traditional methods missed. By recreating the virus’s membrane environment, researchers can better understand how immune defenses work. The technique could speed up the development of more effective vaccines. Sun, 12 Apr 2026 06:42:12 EDT https://www.sciencedaily.com/releases/2026/04/260411022027.htm https://www.sciencedaily.com/releases/2026/04/260409101106.htm Researchers have uncovered why a rare blood clotting disorder can occur after certain COVID-19 vaccines or adenovirus infections. The immune system can mistakenly target a normal blood protein (PF4) after confusing it with a viral protein. This triggers clotting in extremely rare cases. The breakthrough means vaccines can now be redesigned to avoid this reaction while staying effective. Fri, 10 Apr 2026 22:31:35 EDT https://www.sciencedaily.com/releases/2026/04/260409101106.htm https://www.sciencedaily.com/releases/2026/04/260408225950.htm Chronic inflammation often works quietly in the background but can fuel serious diseases like diabetes, heart disease, and cancer. New research reveals that everyday plant compounds—like menthol from mint, cineole from eucalyptus, and capsaicin from chili peppers—can team up inside immune cells to dramatically boost their anti-inflammatory power. While individual compounds showed modest effects, certain combinations amplified results hundreds of times over by activating different cellular pathways at once. Thu, 09 Apr 2026 02:57:22 EDT https://www.sciencedaily.com/releases/2026/04/260408225950.htm https://www.sciencedaily.com/releases/2026/04/260405003949.htm Scientists have identified a potential new weapon against hepatitis E, a virus with no approved treatment and tens of thousands of deaths each year. The drug bemnifosbuvir, currently in trials for hepatitis C, was found to block the virus from replicating by disrupting its genetic machinery. Tests in cells and animals showed strong effectiveness without harming healthy tissue. If ongoing trials succeed, the drug could soon be repurposed for hepatitis E. Mon, 06 Apr 2026 05:00:20 EDT https://www.sciencedaily.com/releases/2026/04/260405003949.htm https://www.sciencedaily.com/releases/2026/04/260402000221.htm A deadly parasite responsible for sleeping sickness has been found using a surprisingly precise trick to stay hidden in the human bloodstream. Scientists discovered a protein called ESB2 that acts like a “molecular shredder,” cutting up specific genetic instructions as they are produced. This allows the parasite to flood its surface with protective proteins while suppressing other signals that might give it away. Thu, 02 Apr 2026 00:31:42 EDT https://www.sciencedaily.com/releases/2026/04/260402000221.htm https://www.sciencedaily.com/releases/2026/04/260401071951.htm Colorectal cancer may carry a unique microbial “fingerprint,” setting it apart from other cancers and opening a new frontier in diagnosis and treatment. By analyzing DNA from over 9,000 patients, researchers discovered that only colorectal tumors consistently host distinct microbial communities—challenging the long-held belief that all cancers have their own microbial signatures. Wed, 01 Apr 2026 23:54:49 EDT https://www.sciencedaily.com/releases/2026/04/260401071951.htm https://www.sciencedaily.com/releases/2026/03/260330001147.htm Scientists have uncovered a surprising secret about our DNA: it’s not a static blueprint, but a constantly shifting, folding structure that helps control how genes turn on and off. Researchers at the Salk Institute found that different parts of the genome loop and unloop at different speeds, with more active regions constantly reshaping themselves to support gene activity. Tue, 31 Mar 2026 06:47:40 EDT https://www.sciencedaily.com/releases/2026/03/260330001147.htm https://www.sciencedaily.com/releases/2026/03/260328024519.htm Scientists have uncovered how your body actually tells your brain to stop eating when you’re sick. In a new study, researchers found that specialized cells in the gut detect parasites and send signals that ultimately trigger the brain to suppress appetite. This process builds over time, explaining why you may feel fine at first but then suddenly lose interest in food as an infection takes hold. Sat, 28 Mar 2026 04:35:02 EDT https://www.sciencedaily.com/releases/2026/03/260328024519.htm https://www.sciencedaily.com/releases/2026/03/260321012638.htm Antibiotics are accumulating in a major Brazilian river, especially during the dry season when pollution becomes more concentrated. Scientists even detected a banned drug inside fish sold for food, raising concerns about human exposure. A common aquatic plant showed promise in removing these chemicals from water—but it also altered how fish absorb them, creating unexpected risks. Sat, 21 Mar 2026 20:48:07 EDT https://www.sciencedaily.com/releases/2026/03/260321012638.htm https://www.sciencedaily.com/releases/2026/03/260319044708.htm Scientists have found a way to make one of the most aggressive brain tumors vulnerable to the immune system. A single injection of a modified virus can invade glioblastoma, kill cancer cells, and summon immune fighters deep into the tumor. These immune cells persist and attack, which was linked to longer survival in patients. Fri, 20 Mar 2026 07:59:34 EDT https://www.sciencedaily.com/releases/2026/03/260319044708.htm https://www.sciencedaily.com/releases/2026/03/260319044659.htm A shingles vaccine might double as a powerful heart protector. In people already at high risk, it cut major cardiac events by 46% and deaths by an impressive 66% within a year. Scientists think preventing shingles may also stop clot-related complications that can lead to heart attacks and strokes. The effect is so strong, it rivals the benefits of quitting smoking. Fri, 20 Mar 2026 08:10:25 EDT https://www.sciencedaily.com/releases/2026/03/260319044659.htm https://www.sciencedaily.com/releases/2026/03/260318033111.htm Malaria parasites contain tiny spinning crystals that have puzzled scientists for years. New research reveals they’re powered by a rocket-like reaction that breaks down hydrogen peroxide, releasing energy. This motion may help the parasite detoxify harmful chemicals and manage iron more efficiently. The discovery could lead to new drugs and spark innovations in microscopic robotics. Thu, 19 Mar 2026 07:19:27 EDT https://www.sciencedaily.com/releases/2026/03/260318033111.htm https://www.sciencedaily.com/releases/2026/03/260317015933.htm mRNA vaccines saved millions of lives during COVID-19 but have limitations like waning immunity and complex production. Scientists are now testing a new platform called DoriVac, which uses folded DNA nanostructures to better control how the immune system responds. In early studies, it produced strong antibody and T cell responses in both mice and human models. Researchers say it could lead to more stable, easier-to-manufacture vaccines for diseases like COVID-19, HIV, and Ebola. Tue, 17 Mar 2026 01:59:33 EDT https://www.sciencedaily.com/releases/2026/03/260317015933.htm https://www.sciencedaily.com/releases/2026/03/260311213453.htm Scientists have discovered that a rare “mirror-image” version of the amino acid cysteine can dramatically slow the growth of certain cancers while leaving healthy cells largely untouched. Unlike most anticancer treatments that harm normal tissues, this molecule—called D-cysteine—is taken up mainly by some cancer cells through a specific transporter on their surface. Once inside, it shuts down a crucial mitochondrial enzyme that cancer cells rely on to produce energy and maintain DNA, effectively halting their growth. Thu, 12 Mar 2026 18:48:39 EDT https://www.sciencedaily.com/releases/2026/03/260311213453.htm https://www.sciencedaily.com/releases/2026/03/260306224238.htm Mayo Clinic researchers have identified a rare mutation in the MET gene that can directly cause metabolic dysfunction-associated steatotic liver disease. The mutation disrupts the liver’s ability to process fat, leading to inflammation, scarring, and potentially cirrhosis. The discovery began with a father and daughter who had the disease without typical risk factors. Large-scale genomic data suggests similar rare variants may quietly contribute to the disease in many more people. Sat, 07 Mar 2026 06:04:29 EST https://www.sciencedaily.com/releases/2026/03/260306224238.htm https://www.sciencedaily.com/releases/2026/03/260306224232.htm A mysterious form of plague that spread across Eurasia thousands of years before the Black Death has finally revealed a crucial clue. Scientists analyzing ancient DNA discovered the bacterium Yersinia pestis in a 4,000-year-old domesticated sheep from a Bronze Age settlement in the Ural Mountains—the first time the pathogen has ever been found in a non-human host from that era. Because this early strain couldn’t spread through fleas like the medieval plague, researchers have long puzzled over how it traveled so widely. Sat, 07 Mar 2026 03:41:28 EST https://www.sciencedaily.com/releases/2026/03/260306224232.htm https://www.sciencedaily.com/releases/2026/03/260305223204.htm Researchers created an AI-driven liquid biopsy that scans patterns in fragments of DNA circulating in the blood. The system detected early liver fibrosis and cirrhosis—conditions that often go unnoticed until serious damage occurs. By analyzing genome-wide DNA fragmentation patterns rather than specific mutations, the approach captures hidden signals about a person’s overall health. Early detection could help doctors treat liver disease sooner and potentially prevent cancer. Fri, 06 Mar 2026 00:20:31 EST https://www.sciencedaily.com/releases/2026/03/260305223204.htm https://www.sciencedaily.com/releases/2026/03/260304184221.htm Scientists have uncovered a crucial weakness in the malaria parasite that could open the door to new treatments. Researchers identified a protein called Aurora-related kinase 1 (ARK1) that acts like a traffic controller during the parasite’s unusual cell division process, ensuring its genetic material is properly separated as it multiplies. When scientists switched off ARK1 in laboratory experiments, the parasite could no longer replicate correctly and failed to complete its life cycle in both humans and mosquitoes—effectively halting its ability to spread. Thu, 05 Mar 2026 00:03:04 EST https://www.sciencedaily.com/releases/2026/03/260304184221.htm https://www.sciencedaily.com/releases/2026/02/260225081153.htm A shingles shot might do more than prevent a painful rash — it could actually help slow down the aging process. In a large national study of more than 3,800 Americans age 70 and older, those who received the shingles vaccine showed slower biological aging compared to those who didn’t. Researchers found lower levels of chronic inflammation and slower changes in gene activity linked to aging, suggesting the vaccine may calm the body’s “inflammaging” — the low-grade inflammation tied to heart disease, frailty, and cognitive decline. Thu, 26 Feb 2026 02:47:45 EST https://www.sciencedaily.com/releases/2026/02/260225081153.htm https://www.sciencedaily.com/releases/2026/02/260222092258.htm Scientists at Stanford Medicine have unveiled a bold new kind of “universal” vaccine that could one day protect against everything from COVID-19 and the flu to bacterial pneumonia and even common allergens. Instead of targeting a specific virus or bacterium, the nasal spray vaccine supercharges the lungs’ own immune defenses, keeping them on high alert for months. In mice, it slashed viral levels, prevented severe illness, and even blocked allergic reactions. Mon, 23 Feb 2026 08:45:18 EST https://www.sciencedaily.com/releases/2026/02/260222092258.htm https://www.sciencedaily.com/releases/2026/02/260217005759.htm A major new study has spotlighted three familiar medicines that could take on an unexpected new role in the fight against Alzheimer’s disease — with a shingles vaccine emerging as the front-runner. After reviewing 80 existing drugs, an international panel of experts identified Zostavax, Viagra (sildenafil), and riluzole as the most promising candidates for repurposing. Wed, 18 Feb 2026 07:02:28 EST https://www.sciencedaily.com/releases/2026/02/260217005759.htm https://www.sciencedaily.com/releases/2026/02/260216044006.htm Northwestern researchers have shown that when it comes to cancer vaccines, arrangement can be just as important as ingredients. By repositioning a small fragment of an HPV protein on a DNA-based nanovaccine, the team dramatically strengthened the immune system’s attack on HPV-driven tumors. One specific design slowed tumor growth, extended survival in animal models, and unleashed far more cancer-killing T cells than other versions made with the exact same components. Wed, 18 Feb 2026 10:00:32 EST https://www.sciencedaily.com/releases/2026/02/260216044006.htm https://www.sciencedaily.com/releases/2026/02/260215225602.htm A parasite that may already be hiding in your brain has a shocking survival trick: it can infect the very immune cells sent to destroy it. Yet most people never get sick, and new research from UVA Health reveals why. Scientists discovered that when Toxoplasma gondii invades CD8+ T cells — key defenders of the immune system — those cells can trigger a self-destruct mechanism powered by an enzyme called caspase-8. By sacrificing themselves, the infected cells also wipe out the parasite inside them. Mon, 16 Feb 2026 08:33:46 EST https://www.sciencedaily.com/releases/2026/02/260215225602.htm https://www.sciencedaily.com/releases/2026/02/260215085001.htm Researchers tracked more than 400 toddlers to see whether mRNA COVID-19 vaccination during or just before pregnancy was linked to autism or developmental delays. After detailed assessments of speech, motor skills, behavior, and social development, they found no meaningful differences between vaccinated and unvaccinated groups. Experts say the results provide strong reassurance about vaccine safety in pregnancy. Sun, 15 Feb 2026 09:51:05 EST https://www.sciencedaily.com/releases/2026/02/260215085001.htm https://www.sciencedaily.com/releases/2026/02/260210040608.htm Why does the same virus barely faze one person while sending another to the hospital? New research shows the answer lies in a molecular record etched into our immune cells by both our genes and our life experiences. Scientists at the Salk Institute have created a detailed epigenetic map of human immune cells, revealing how inherited traits and past exposures—like infections, vaccines, or even environmental chemicals—shape immune responses in different ways. Wed, 11 Feb 2026 00:02:01 EST https://www.sciencedaily.com/releases/2026/02/260210040608.htm https://www.sciencedaily.com/releases/2026/02/260208011017.htm Your gut is home to trillions of bacteria that constantly “sense” their surroundings to survive and thrive. New research shows that beneficial gut microbes, especially common Clostridia bacteria, can detect a surprisingly wide range of chemical signals produced during digestion, including byproducts of fats, proteins, sugars, and even DNA. These microbes use specialized sensors to move toward valuable nutrients, with lactate and formate standing out as especially important fuel sources. Sun, 08 Feb 2026 15:56:24 EST https://www.sciencedaily.com/releases/2026/02/260208011017.htm https://www.sciencedaily.com/releases/2026/02/260206232245.htm New research suggests that Epstein-Barr virus may actively provoke the immune system in people with multiple sclerosis. Scientists found large buildups of virus-targeting immune cells in the nervous systems of MS patients, far more than in their blood. One viral gene was active only in people with MS, hinting at a direct role in the disease. The findings could help guide new approaches to treatment. Fri, 06 Feb 2026 23:22:45 EST https://www.sciencedaily.com/releases/2026/02/260206232245.htm https://www.sciencedaily.com/releases/2026/02/260204114343.htm As bird flu continues to circulate in animals and spill over into humans, researchers are racing to stop it before it adapts to spread widely between people. A new nasal spray vaccine showed strong protection against H5N1 in animal tests, outperforming traditional flu shots. Because it targets the nose and lungs, it may prevent infection at the earliest stage. Wed, 04 Feb 2026 11:43:43 EST https://www.sciencedaily.com/releases/2026/02/260204114343.htm https://www.sciencedaily.com/releases/2026/01/260131084131.htm Researchers in Bangladesh have identified a bat-borne virus, Pteropine orthoreovirus, in patients who were initially suspected of having Nipah virus but tested negative. All had recently consumed raw date-palm sap, a known pathway for bat-related infections. Genetic analysis confirmed live virus in several samples, pointing to active human infection. The finding raises concerns that dangerous bat viruses may be circulating undetected alongside Nipah. Sun, 01 Feb 2026 01:46:23 EST https://www.sciencedaily.com/releases/2026/01/260131084131.htm https://www.sciencedaily.com/releases/2026/01/260128075345.htm Two decades after a breast cancer vaccine trial, every participant is still alive—an astonishing result for metastatic disease. Scientists found their immune systems retained long-lasting memory cells primed to recognize cancer. By enhancing a key immune signal called CD27, researchers dramatically improved tumor elimination in lab studies. The findings suggest cancer vaccines may have been missing a crucial ingredient all along. Fri, 30 Jan 2026 01:13:54 EST https://www.sciencedaily.com/releases/2026/01/260128075345.htm https://www.sciencedaily.com/releases/2026/01/260127112124.htm A common parasite long thought to lie dormant is actually much more active and complex. Researchers found that Toxoplasma gondii cysts contain multiple parasite subtypes, not just one sleeping form. Some are primed to reactivate and cause disease, which helps explain why infections are so hard to treat. The discovery could reshape efforts to develop drugs that finally eliminate the parasite for good. Tue, 27 Jan 2026 23:11:20 EST https://www.sciencedaily.com/releases/2026/01/260127112124.htm https://www.sciencedaily.com/releases/2026/01/260125083349.htm A 5,500-year-old skeleton from Colombia has revealed the oldest known genome of the bacterium linked to syphilis and related diseases. The ancient strain doesn’t fit neatly into modern categories, hinting at a forgotten form that split off early in the pathogen’s evolution. This pushes the history of treponemal diseases in the Americas back by millennia and shows they were already diversifying long before written records. Mon, 26 Jan 2026 06:04:05 EST https://www.sciencedaily.com/releases/2026/01/260125083349.htm https://www.sciencedaily.com/releases/2026/01/260122074702.htm Scientists found that nasal cells act as a first line of defense against the common cold, working together to block rhinovirus soon after infection. A fast antiviral response can stop the virus before symptoms appear. If that response is weakened or delayed, the virus spreads and causes inflammation and breathing problems. The study highlights why the body’s reaction matters more than the virus alone. Thu, 22 Jan 2026 08:15:47 EST https://www.sciencedaily.com/releases/2026/01/260122074702.htm https://www.sciencedaily.com/releases/2026/01/260120000305.htm A new study suggests that micro-doses of THC could help counter many long-term side effects of HIV treatment without causing intoxication. In animal models, low-dose THC reduced inflammation, improved gut bacteria, boosted serotonin, and lowered harmful cholesterol and bile acids. Surprisingly, it also reduced circulating levels of antiretroviral drugs while maintaining viral suppression, potentially protecting the liver. Scientists say the results point to a promising new approach for managing chronic complications of HIV. Wed, 21 Jan 2026 01:36:19 EST https://www.sciencedaily.com/releases/2026/01/260120000305.htm https://www.sciencedaily.com/releases/2026/01/260118233553.htm A major new scientific review brings reassuring news for expectant parents: using acetaminophen, commonly known as Tylenol, during pregnancy does not increase a child’s risk of autism, ADHD, or intellectual disability. Researchers analyzed 43 high-quality studies, including powerful sibling comparisons that help separate medication effects from genetics and family environment. Earlier warnings appear to have been driven by underlying maternal health factors such as fever or pain rather than the medication itself. Mon, 19 Jan 2026 09:48:41 EST https://www.sciencedaily.com/releases/2026/01/260118233553.htm https://www.sciencedaily.com/releases/2026/01/260118064637.htm When scientists sent bacteria-infecting viruses to the International Space Station, the microbes did not behave the same way they do on Earth. In microgravity, infections still occurred, but both viruses and bacteria evolved differently over time. Genetic changes emerged that altered how viruses attach to bacteria and how bacteria defend themselves. The findings could help improve phage therapies against drug-resistant infections. Sun, 18 Jan 2026 09:54:24 EST https://www.sciencedaily.com/releases/2026/01/260118064637.htm https://www.sciencedaily.com/releases/2026/01/260110211204.htm In a striking real-world experiment, flu patients spent days indoors with healthy volunteers, but the virus never spread. Researchers found that limited coughing and well-mixed indoor air kept virus levels low, even with close contact. Age may have helped too, since middle-aged adults are less likely to catch the flu than younger people. The results highlight ventilation, air movement, and masks as key defenses against infection. Sun, 11 Jan 2026 02:45:57 EST https://www.sciencedaily.com/releases/2026/01/260110211204.htm https://www.sciencedaily.com/releases/2026/01/260107225541.htm DNA doesn’t just sit still inside our cells — it folds, loops, and rearranges in ways that shape how genes behave. Researchers have now mapped this hidden architecture in unprecedented detail, showing how genome structure changes from cell to cell and over time. These insights reveal why many disease-linked mutations outside genes can still cause harm. The findings could speed up the discovery of genetic risks and inspire new ways to target diseases. Thu, 08 Jan 2026 21:16:11 EST https://www.sciencedaily.com/releases/2026/01/260107225541.htm https://www.sciencedaily.com/releases/2026/01/260107225532.htm Long COVID affects an estimated 65 million people worldwide and can damage the brain, heart, blood vessels, and immune system long after infection. Researchers now link symptoms to lingering virus, inflammation, micro-clots, and disrupted energy metabolism. While structured rehab and pacing can improve quality of life, a growing list of experimental treatments—from antivirals and metformin to microbiome therapies and biologics—shows early promise. Clear answers, however, are still limited by small studies and the lack of large, definitive trials. Thu, 08 Jan 2026 19:57:41 EST https://www.sciencedaily.com/releases/2026/01/260107225532.htm https://www.sciencedaily.com/releases/2026/01/260107225527.htm Scientists are uncovering why Brazil may be one of the most important yet underused resources for studying extreme longevity. Its highly diverse population harbors millions of genetic variants missing from standard datasets, including rare changes linked to immune strength and cellular maintenance. Brazilian supercentenarians often remain mentally sharp, survive serious infections, and come from families where multiple members live past 100. Together, they reveal aging not as inevitable decline, but as a form of biological resilience. Thu, 08 Jan 2026 08:31:49 EST https://www.sciencedaily.com/releases/2026/01/260107225527.htm https://www.sciencedaily.com/releases/2026/01/260105165820.htm Scientists have uncovered a surprising viral shortcut that turns moving cells into delivery vehicles for infection. Instead of spreading one virus at a time, infected cells bundle viral material into large structures called Migrions and pass them directly to new cells. This collective delivery jump-starts viral replication and boosts disease severity. The finding reveals a migration-based route of viral spread that defies classic models of infection. Mon, 05 Jan 2026 21:34:44 EST https://www.sciencedaily.com/releases/2026/01/260105165820.htm https://www.sciencedaily.com/releases/2026/01/260105165818.htm A long-running debate over Tamiflu’s safety in children may finally be settled. Researchers found that influenza, not the antiviral medication, was linked to serious neuropsychiatric events like seizures and hallucinations. Even more striking, kids treated with Tamiflu had about half the risk of these events compared to untreated children with the flu. The results suggest the drug may be protective rather than harmful. Mon, 05 Jan 2026 20:48:09 EST https://www.sciencedaily.com/releases/2026/01/260105165818.htm https://www.sciencedaily.com/releases/2025/12/251227082716.htm Stanford scientists have uncovered how mRNA COVID-19 vaccines can very rarely trigger heart inflammation in young men — and how that risk might be reduced. They found that the vaccines can spark a two-step immune reaction that floods the body with inflammatory signals, drawing aggressive immune cells into the heart and causing temporary injury. Sat, 27 Dec 2025 10:52:27 EST https://www.sciencedaily.com/releases/2025/12/251227082716.htm https://www.sciencedaily.com/releases/2025/12/251221043237.htm A Brazilian study has confirmed that Joseph’s Coat, a plant used for generations in folk medicine, can significantly reduce inflammation and arthritis symptoms in lab tests. Researchers observed less swelling, healthier joints, and signs of tissue protection. Just as important, the extract showed a promising safety profile at tested doses. The discovery could pave the way for new plant-based anti-inflammatory treatments. Mon, 22 Dec 2025 00:46:08 EST https://www.sciencedaily.com/releases/2025/12/251221043237.htm https://www.sciencedaily.com/releases/2025/12/251215084155.htm Researchers discovered a hidden molecular “switch” that herpes viruses rely on to invade cells. By combining AI, simulations, and lab experiments, they identified and altered a single amino acid that shut down viral entry. What once might have taken years was achieved far faster using computational tools. The findings open new possibilities for designing future antiviral treatments. Mon, 15 Dec 2025 09:45:33 EST https://www.sciencedaily.com/releases/2025/12/251215084155.htm https://www.sciencedaily.com/releases/2025/12/251214100928.htm Researchers tracking over 63,000 adults found that high-quality, minimally processed plant foods significantly reduce cardiovascular risk. But when those plant foods are ultra-processed, the advantage disappears—and can even backfire. Some ultra-processed plant diets increased risk by 40%. The study urges a shift toward whole, naturally nutrient-rich plant foods. Mon, 15 Dec 2025 08:55:31 EST https://www.sciencedaily.com/releases/2025/12/251214100928.htm https://www.sciencedaily.com/releases/2025/12/251214100911.htm Scientists are uncovering a new possibility behind long COVID’s stubborn symptoms: hidden infections that awaken or emerge alongside SARS-CoV-2. Evidence is mounting that viruses like Epstein-Barr and even latent tuberculosis may flare up when COVID disrupts the immune system, creating lingering fatigue, brain fog, and other debilitating issues. Sun, 14 Dec 2025 22:36:14 EST https://www.sciencedaily.com/releases/2025/12/251214100911.htm https://www.sciencedaily.com/releases/2025/12/251212204834.htm Researchers used AI to pinpoint a little-known monkeypox protein that provokes strong protective antibodies. When the team tested this protein as a vaccine ingredient in mice, it produced a potent immune response. The discovery could lead to simpler, more effective mpox vaccines and therapies. It may also help guide future efforts against smallpox. Fri, 12 Dec 2025 21:09:27 EST https://www.sciencedaily.com/releases/2025/12/251212204834.htm https://www.sciencedaily.com/releases/2025/12/251210092015.htm Northwestern scientists have created the fastest-ever hepatitis C diagnostic, delivering accurate results in only 15 minutes. The test uses the DASH rapid PCR system, originally developed for COVID, but adapted for whole blood samples. Independent testing showed 100% agreement with existing commercial platforms. Its speed could transform how quickly patients begin treatment. Thu, 11 Dec 2025 02:36:56 EST https://www.sciencedaily.com/releases/2025/12/251210092015.htm https://www.sciencedaily.com/releases/2025/12/251203004721.htm A unique vaccine rollout in Wales gave researchers an accidental natural experiment that revealed a striking reduction in dementia among seniors who received the shingles vaccine. The protective effect held steady across multiple analyses and was even stronger in women. Evidence also suggests benefits for people who already have dementia, hinting at a therapeutic effect. Wed, 03 Dec 2025 10:22:27 EST https://www.sciencedaily.com/releases/2025/12/251203004721.htm https://www.sciencedaily.com/releases/2025/11/251128050503.htm Researchers discovered why bird flu can survive temperatures that stop human flu in its tracks. A key gene, PB1, gives avian viruses the ability to replicate even at fever-level heat. Mice experiments confirmed that fever cripples human-origin flu but not avian strains, especially those with avian-like PB1. These findings highlight how gene swapping could fuel future pandemics. Fri, 28 Nov 2025 07:37:38 EST https://www.sciencedaily.com/releases/2025/11/251128050503.htm https://www.sciencedaily.com/releases/2025/11/251124094334.htm University of Queensland researchers visualized yellow fever virus particles at near-atomic detail, uncovering major structural differences between vaccine and virulent strains. The insights could lead to better vaccines and treatments for yellow fever and related mosquito-borne viruses. Thu, 27 Nov 2025 09:30:23 EST https://www.sciencedaily.com/releases/2025/11/251124094334.htm https://www.sciencedaily.com/releases/2025/11/251124094317.htm Participants lost more weight on a low-fat vegan diet than on the Mediterranean diet, largely due to eliminating animal foods and reducing oils and nuts. Increased intake of plant foods, even “unhealthy” ones, was strongly associated with greater weight loss. Mon, 24 Nov 2025 11:03:07 EST https://www.sciencedaily.com/releases/2025/11/251124094317.htm https://www.sciencedaily.com/releases/2025/11/251117095635.htm Scientists mapped the Bas63 bacteriophage in unprecedented detail, uncovering how its tail machinery infects bacteria. The structure reveals rare whisker-collar features and distant evolutionary ties reaching back billions of years. These insights could guide new phage therapies and innovations in medicine, agriculture, and industry. Mon, 17 Nov 2025 10:32:09 EST https://www.sciencedaily.com/releases/2025/11/251117095635.htm https://www.sciencedaily.com/releases/2025/11/251105050708.htm Researchers discovered how rabies virus exerts massive control over host cells with very few genes. A key viral protein changes shape and binds RNA, allowing it to infiltrate different cellular systems. This adaptability could explain the power of other deadly viruses, including Nipah and Ebola. The breakthrough may lead to next-generation antivirals or vaccines. Wed, 05 Nov 2025 05:30:55 EST https://www.sciencedaily.com/releases/2025/11/251105050708.htm https://www.sciencedaily.com/releases/2025/11/251104094136.htm Researchers have, for the first time, estimated how quickly E. coli bacteria can spread between people — and one strain moves as fast as swine flu. Using genomic data from the UK and Norway, scientists modeled bacterial transmission rates and discovered key differences between strains. Their work offers a new way to monitor and control antibiotic-resistant bacteria in both communities and hospitals. Tue, 04 Nov 2025 23:25:35 EST https://www.sciencedaily.com/releases/2025/11/251104094136.htm https://www.sciencedaily.com/releases/2025/11/251102205021.htm A team of scientists has developed a highly accurate blood test for Chronic Fatigue Syndrome. The test reads tiny DNA patterns that reveal the biological signature of the illness. For millions who’ve faced doubt and misdiagnosis, it’s a breakthrough that finally validates their experience — and may help diagnose long Covid too. Mon, 03 Nov 2025 02:22:12 EST https://www.sciencedaily.com/releases/2025/11/251102205021.htm https://www.sciencedaily.com/releases/2025/11/251102205009.htm Penn State scientists uncovered an ancient bacterial defense where dormant viral DNA helps bacteria fight new viral threats. The enzyme PinQ flips bacterial genes to create protective proteins that block infection. Understanding this mechanism could lead to breakthroughs in antivirals, antibiotic alternatives, and industrial microbiology. Mon, 03 Nov 2025 09:05:12 EST https://www.sciencedaily.com/releases/2025/11/251102205009.htm